INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 213 filers reported holding INSMED INC in Q4 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $530 | +19.6% | 21 | 0.0% | 0.00% | – |
| Q2 2023 | $443 | +23.7% | 21 | 0.0% | 0.00% | – |
| Q1 2023 | $358 | -14.8% | 21 | 0.0% | 0.00% | – |
| Q4 2022 | $420 | – | 21 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 21 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 21 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 21 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 21 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 21 | -41.7% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 36 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | -50.0% | 36 | -36.8% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 57 | -3.4% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 59 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 59 | +7.3% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 55 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 55 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 55 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | – | 55 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |